top of page
News, Events and Updates
Search
Low density of sigma-1 receptors in early Alzheimer’s disease.
Apr 10, 2008
ANAVEX 7-1037 Reduces Rate of Cancer Tumor Growth 69% in Pre-Clinical Studies, Compared to Currently
Mar 10, 2008
Anavex Outlines Corporate Milestones, Drug Advancement Plans for 2008
Jan 22, 2008
Anavex Advances Drug Candidate for Treatment of Alzheimer’s Disease
Dec 28, 2007
Anavex Strengthens Board of Directors
Dec 17, 2007
ANAVEX 7-1037 Demonstrates Chemotherapeutic Potential Without Toxic Side Effects
Dec 11, 2007
Anavex Advances Drug Candidates for Treatment of Epilepsy
Dec 6, 2007
Anavex Life Sciences Engages Primoris Group to Provide Investor Relations Services
Nov 2, 2007
Annual General Meeting of the Shareholders of Anavex Life Sciences Corp.
Jun 5, 2007
Preclinical Data of ANAVEX 1-41 & ANAVEX 2-73 Show Highly Potent Anti-Amnesic & Neuroprotective...
May 23, 2007
Dr. Jean Jacques Bourguignon Joins Anavex Life Sciences Corp. Scientific Team
Apr 16, 2007
46
47
48
49
50
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
